Champions Oncology, Inc.CSBRNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P67
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-898000.00-114.3%
2025$6.29M+216.3%
2024$-5.41M-161.6%
2023$-2.07M-169.1%
2022$3.00M+48.4%
2021$2.02M+374.7%
2020$-735000.00-187.8%
2019$837000.00+177.3%
2018$-1.08M+83.8%
2017$-6.70M-